Abbott's Xience Xpedition 48 Drug-Eluting Stent System Honored as One of 'Top 10 Medical Devices for Healthy China 2019,' Driving Innovation to Support Healthy China 2030

At the award ceremony of the 12th Healthy China Forum (2019), co-hosted by People’s Daily Online and Health Times, Abbott, a global leader in healthcare, was once again honored: The Xience Xpedition 48 drug-eluting coronary stent system, currently the only longest stent marketed in China, was awarded “Top Ten Medical Devices of Healthy China (2019).” This follows last year’s recognition of Abbott’s FreeStyle®Following its strong entry into the “Top 10 Medical Devices of Healthy China (2018),” the FreeStyle Libre continuous glucose monitoring system has once again earned industry recognition for its innovative technological products and services.

The Abbott Xience Xpedition 48 Drug-Eluting Coronary Stent System was approved for marketing in China in August 2019. With a length of 48 mm, it is the longest stent available on the Chinese market. It also holds indications approved by the U.S. Food and Drug Administration (FDA) for patients with diabetes and for chronic total occlusion (CTO) lesions, being the first globally to receive such approval for CTO. The excellent deliverability of the Xience Xpedition 48 Drug-Eluting Coronary Stent System enables more effective management of complex long lesions, reduces the number of stents required, significantly shortens procedural and hospitalization times, lowers procedural and medical insurance costs, and decreases both the consumables-to-revenue ratio and patient financial burden. Studies have shown that the use of a single ultra-long stent in complex coronary artery disease lesions can reduce angiography time by 23%.1, 50% reduction in contrast agent usage2. Surgical time reduced by 45%3, surgical costs reduced by 31%4The Xience Xpedition 48 stent, which offers the dual benefits of clinical safety and health economic value, provides Chinese physicians and patients with the concept and outcomes of “minimalist therapy,” thereby distinguishing it from numerous other candidate medical devices.stood out and successfully ranked among the “Top 10 Medical Devices of Healthy China (2019).”

Jiang Tuo, Vice President of Abbott’s Cardiovascular business and General Manager for Greater China, accepted the award on behalf of the company. The Xience Xpedition 48 drug-eluting coronary stent enables “deep-seated implantation” to treat lesions, delivering therapeutic benefits that are “long-lasting.” Furthermore, 2019 marked the 10th anniversary of the introduction of the Xience series of drug-eluting coronary stents into China. As a global leader in cardiovascular care, Abbott remains committed to helping people regain healthy lives through cutting-edge technologies. Standing at the dawn of another decade in 2020, Abbott will continue to bring more innovative products and services to fully support the Healthy China 2030 initiative.

As a global leader in healthcare, Abbott brings cutting-edge technology to life and health, helping people live their best lives. Abbott provides nutritional support across all stages of life, helps maintain heart health, alleviates chronic pain, and improves mobility. By delivering information, pharmaceuticals, and advanced technologies, Abbott empowers individuals to better manage their health. Through personalized medical technologies, Abbott enables people to live healthier lives and fully enjoy the joys of life. In the fields of diagnostics, medical devices, nutrition, and pharmaceuticals, Abbott continuously develops breakthrough innovative products that promote health and unlock endless possibilities for life.

References:

1. Conduct clinical trials at Abbott and archive the data

2. Conduct clinical trials at Abbott and archive the data

3. Conduct clinical trials at Abbott and archive data

 4.Hoffmann, R., et al. Randomized Comparison of Success and Adverse Event Rates and Cost Effectiveness of One Long Versus Two Short Stents for Treatment of Long Coronary Narrowings. Am J Cardiol. 2002;90:460?464.